Chemical Component Summary

Name4-fluoro-2-(4-fluorophenyl)-N-methyl-5-(2-methyl-5-{[1-(pyrimidin-2-yl)cyclopropyl]carbamoyl}phenyl)-1-benzofuran-3-carboxamide
Identifiers4-fluoranyl-2-(4-fluorophenyl)-~{N}-methyl-5-[2-methyl-5-[(1-pyrimidin-2-ylcyclopropyl)carbamoyl]phenyl]-1-benzofuran-3-carboxamide
FormulaC31 H24 F2 N4 O3
Molecular Weight538.544
TypeNON-POLYMER
Isomeric SMILESCc1ccc(cc1c2ccc3c(c2F)c(c(o3)c4ccc(cc4)F)C(=O)NC)C(=O)NC5(CC5)c6ncccn6
InChIInChI=1S/C31H24F2N4O3/c1-17-4-5-19(28(38)37-31(12-13-31)30-35-14-3-15-36-30)16-22(17)21-10-11-23-24(26(21)33)25(29(39)34-2)27(40-23)18-6-8-20(32)9-7-18/h3-11,14-16H,12-13H2,1-2H3,(H,34,39)(H,37,38)
InChIKeyLZAUGCMVNLZVJV-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count64
Chiral Atom Count0
Bond Count69
Aromatic Bond Count28

Drug Info: DrugBank

DrugBank IDDB14950 
NameBMS-929075
Groups investigational
DescriptionBMS-929075 is under investigation in clinical trial NCT01525212 (Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients).
SynonymsBMS-929075
CAS number1217338-97-0

Related Resource References

Resource NameReference
PubChem 59275404
ChEMBL CHEMBL4093031
CCDC/CSD RAXXOG